← Back to Search

Oral care treatment group for Pneumonia

N/A
Waitlist Available
Led By Trudy L. Robertson, MSN
Research Sponsored by Fraser Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 months
Awards & highlights

Summary

Hypothesis: The investigators hypothesize that the current oral protocol is sub-optimal and an enhanced protocol will decrease the incidence of hospital acquired pneumonia (HAP)in the acute, non-intubated, care-dependent, neurologically impaired, adult patient.

Eligible Conditions
  • Pneumonia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hospital Acquired Pneumonia Occurrences

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Oral care treatment groupExperimental Treatment1 Intervention
All subjects in the prospective intervention group will receive the same enhanced oral care protocol
Group II: Retrospective study groupActive Control1 Intervention
For comparison purposes, a retrospective chart review of matched in-patient population will reveal pneumonia rates in the same population who did not receive the enhanced oral care protocol.

Find a Location

Who is running the clinical trial?

Fraser HealthLead Sponsor
46 Previous Clinical Trials
707,558 Total Patients Enrolled
Trudy L. Robertson, MSNPrincipal InvestigatorFraser Health Authority
Dulcie J. Carter, MMedSciPrincipal InvestigatorFraser Health Authority
~2 spots leftby Sep 2025